Crossover Bioequivalence Study of Irbesartan HCTZ 300/25 mg Tablets Under Fasted Conditions

NCT01712139 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Irbesartan and Hydrochlorothiazide
DRUG: Avalide

Sponsor

Roxane Laboratories